ArticleArchives of pharmacal research2026
Entrectinib attenuates LPS-induced neuroinflammation by inhibiting JNK, p38, and AKT pathways and ameliorates cognitive impairment.
Hanwoong Woo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.